• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Genomics PLC

Bupa to offer first genetic test for disease prediction in UK

February 24, 2025
Avenzo Therapeutics

Exclusive: Avenzo picks up another ADC, this time with multi-partnered DualityBio

January 7, 2025
Element Biosciences

Element Biosciences AVITI Sequencing

December 13, 2024
Xaira Therapeutics

Eye On AI: Funding To Biotech And Healthcare Startups Using AI Takes Off After Dip In 2023

December 12, 2024
Sollis Health

Sollis Health: Concierge Medicine Provider Company Secures $33 Million (Series B)

December 8, 2024
Foresight Diagnostics

Foresight Diagnostics Launches Lymphoma Personalized Treatment Clinical Trial

December 5, 2024
Relay Therapeutics

Top Story Relay zeroes in on breast cancer subgroup for pivotal PI3Kα inhibitor study

December 2, 2024
Element Biosciences

How Element Biosciences pushes the boundary of innovation

November 20, 2024
Avenzo Therapeutics

Exclusive: Athena Countouriotis’ Avenzo taps Shanghai biotech for ADC, adds new funds

November 18, 2024
Seaport Therapeutics

Seaport Therapeutics adds another $225 million to coffers to embrace the ‘golden age of neuroscience’

October 21, 2024
Page 2 of 26«12345...1020...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close